Department of Surgery, University of Utah School of Medicine, 30 N 1900 E 3b400, Salt Lake City, UT 84132, USA.
Support Care Cancer. 2013 Aug;21(8):2125-36. doi: 10.1007/s00520-013-1773-z. Epub 2013 Mar 6.
Distress is prevalent in breast cancer patients and can be detrimental to quality of life, performance status, treatment adherence, and satisfaction with medical care. The National Comprehensive Cancer Network developed the distress thermometer (DT) as a self-assessment tool for screening distress in cancer patients. Given time and financial constraints, it is important to refine screening criteria to identify patients with elevated risk for distress. In this study, we identify clinical and epidemiological factors that are associated with an increased likelihood of elevated DT scores (≥ 4 and ≥ 7).
We assessed 229 female patients with the DT at their initial consultation for breast cancer at the Huntsman Cancer Hospital between September 2007 and December 2008. Descriptive statistics and logistic regression models were used to analyze DT and patient data.
Patients undergoing their initial distress thermometer screening within 30 days of receiving a diagnosis of breast cancer had the highest likelihood of scoring ≥ 4 and ≥ 7 on the DT screening tool. Emotional and physical concerns were associated with scores ≥ 4 and scores ≥ 7. Spiritual concerns became significant in patients reporting scores ≥ 7. Patients who were non-Caucasian, unemployed, had a prior history of depression, presented for recurrent disease, or who had been recently diagnosed had a higher likelihood of scores ≥ 4 and scores ≥ 7.
Four groups of patients should be targeted for aggressive screening; patients with a prior diagnosis of depression, patients presenting with recurrent disease, unemployed patients, and non-Caucasian patients. Interventions should address physical, emotional, and spiritual concerns.
在乳腺癌患者中,困扰很常见,可能会对生活质量、身体状况、治疗依从性和对医疗护理的满意度产生不利影响。美国国家综合癌症网络(National Comprehensive Cancer Network)开发了困扰温度计(Distress Thermometer,DT)作为一种自我评估工具,用于筛查癌症患者的困扰。由于时间和经济限制,需要完善筛选标准,以确定有较高困扰风险的患者。本研究旨在确定与 DT 评分升高(≥4 分和≥7 分)相关的临床和流行病学因素。
我们评估了 2007 年 9 月至 2008 年 12 月在亨茨曼癌症医院(Huntsman Cancer Hospital)接受乳腺癌初始咨询的 229 名女性患者的 DT。使用描述性统计和逻辑回归模型分析 DT 和患者数据。
在诊断乳腺癌后 30 天内接受初始 DT 筛查的患者,DT 评分≥4 分和≥7 分的可能性最高。情绪和身体问题与 DT 评分≥4 分和≥7 分相关。在报告 DT 评分≥7 分的患者中,精神问题变得显著。非白种人、失业、有抑郁病史、复发疾病、近期诊断的患者更有可能出现 DT 评分≥4 分和≥7 分。
应针对以下四类患者进行强化筛查:有抑郁病史的患者、复发疾病的患者、失业患者和非白种人患者。干预措施应针对身体、情绪和精神问题。